Lipophilic Prodrug of Methotrexate in the Membrane of Liposomes Promotes Their Uptake by Human Blood Phagocytes.

作者: D. C. Tretiakova , S. V. Khaidukov , A. A. Babayants , I. S. Frolova , O. N. Shcheglovitova

DOI: 10.32607/ACTANATURAE.10946

关键词:

摘要: Previously, we showed that incorporation of methotrexate (MTX) in the form a lipophilic prodrug (MTXDG) 100-nm lipid bilayer liposomes egg phosphatidylcholine can allow one to reduce toxicity and improve antitumor efficiency MTX mouse model T-cell leukemic lymphoma. However, our hemocompatibility tests vitro, caused complement (C) activation, obviously due binding on liposome surface fragmentation C3 factor. In this work, studied interactions carrying stabilizing molecules phosphatidylinositol (PI), ganglioside GM1, or conjugate N-carboxymethylated oligoglycine (CMG) with subpopulations human blood leukocytes. Liposomes labeled BODIPY-phosphatidylcholine were incubated whole (30 min 1 h, 37°C), cells lysed hypotonic buffer, fluorescence bound but not internalized by leukocytes was quenched crystal violet. Cell suspensions analyzed flow cytometry. Incorporation MTXDG dramatically enhanced phagocytosis any composition monocytes. Neutrophils consumed much less liposomes. Lymphocytes did accumulate The introduction PI into practically affect specific consumption monocytes, while CMG likely increase rate regardless presence MTXDG. GM1 presumably shielded from monocyte populations increased uptake another population, probably expressing C3b-binding receptors (C3b detected after incubation plasma). shown have different effects TNF-α production activated leukocytes, depending structure molecule.

参考文章(39)
Michael E. Weinblatt, Methotrexate in rheumatoid arthritis: a quarter century of development. Transactions of the American Clinical and Climatological Association. ,vol. 124, pp. 16- 25 ,(2013)
Qi Yang, Samuel K. Lai, Anti-PEG immunity: emergence, characteristics, and unaddressed questions Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. ,vol. 7, pp. 655- 677 ,(2015) , 10.1002/WNAN.1339
A Ferrante, R E Staugas, B Rowan-Kelly, S Bresatz, L M Kumaratilake, C M Rzepczyk, G R Adolf, Production of tumor necrosis factors alpha and beta by human mononuclear leukocytes stimulated with mitogens, bacteria, and malarial parasites. Infection and Immunity. ,vol. 58, pp. 3996- 4003 ,(1990) , 10.1128/IAI.58.12.3996-4003.1990
Janos Szebeni, Franco Muggia, Alberto Gabizon, Yechezkel Barenholz, Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention. Advanced Drug Delivery Reviews. ,vol. 63, pp. 1020- 1030 ,(2011) , 10.1016/J.ADDR.2011.06.017
Stefan Tenzer, Dominic Docter, Jörg Kuharev, Anna Musyanovych, Verena Fetz, Rouven Hecht, Florian Schlenk, Dagmar Fischer, Klytaimnistra Kiouptsi, Christoph Reinhardt, Katharina Landfester, Hansjörg Schild, Michael Maskos, Shirley K. Knauer, Roland H. Stauber, Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology Nature Nanotechnology. ,vol. 8, pp. 772- 781 ,(2013) , 10.1038/NNANO.2013.181
Jürgen Kopitz, Carolina von Reitzenstein, Maria Burchert, Michael Cantz, Hans-Joachim Gabius, Galectin-1 is a major receptor for ganglioside GM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture. Journal of Biological Chemistry. ,vol. 273, pp. 11205- 11211 ,(1998) , 10.1074/JBC.273.18.11205
Qian Ding, Xiaofei Si, Dan Liu, Jinliang Peng, Hailing Tang, Wenqiang Sun, Mengjie Rui, Qunli Chen, Lieyi Wu, Yuhong Xu, Targeting and liposomal drug delivery to CD40L expressing T cells for treatment of autoimmune diseases Journal of Controlled Release. ,vol. 207, pp. 86- 92 ,(2015) , 10.1016/J.JCONREL.2015.03.035
Yechezkel (Chezy) Barenholz, Doxil®--the first FDA-approved nano-drug: lessons learned. Journal of Controlled Release. ,vol. 160, pp. 117- 134 ,(2012) , 10.1016/J.JCONREL.2012.03.020
Natalia R. Kuznetsova, Chantal Sevrin, David Lespineux, Nicolai V. Bovin, Elena L. Vodovozova, Tamás Mészáros, Janos Szebeni, Christian Grandfils, Hemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayer. Journal of Controlled Release. ,vol. 160, pp. 394- 400 ,(2012) , 10.1016/J.JCONREL.2011.12.010
A. Gabizon, D. Papahadjopoulos, Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 85, pp. 6949- 6953 ,(1988) , 10.1073/PNAS.85.18.6949